HOME >> MEDICINE >> NEWS
International Panel Evaluates Testing For Drug Resistance In HIV

Tests that measure whether the strains of HIV infecting a patient are resistent to antiviral drugs may be useful in helping plan treatment strategies, but more information is needed to determine the best usage of such tests, says an international panel of AIDS experts. In a report appearing in the June 24 issue of the Journal of the American Medical Association, the panel convened by the International AIDS Society-USA outlines several implications of and recommendations regarding testing for drug resistance in HIV. The study's lead author is Martin Hirsch, MD, director of Clincal AIDS Research at the Massachusetts General Hospital and professor of Medicine at Harvard Medical School (HMS).

"It is clear that viral resistance, the existence or development of strains of HIV that can escape the effects of particular antiviral drugs, is an important reason why drug treatment fails some patients," Hirsch says. "While there is not yet enough data available to recommend which of the available tests is best in particular situations, we do believe that resistance information may be useful in guiding treatment, particularly in areas where resistant strains are prevalent."

The panel was made up of 13 physicians from six countries, experts in AIDS treatment and in research relevant to the issue of resistance. The group was convened by the International AIDS Society-USA as part of their effort to monitor and address areas of controversy in the treatment of HIV-related disease. The panel reviewed existing information from published reports, research conference presentations, basic and clinical research studies and information from the manufacturers of available resistance assays and met regularly over a six-month period to develop their report.

Among the group's conclusions are the following:

  • Initiation of drug treatment and changes in treatment regimens should be guided by standard measures of the progress of infection--blood tests that measure th
    '"/>


Contact: Susan McGreevey
smcgreevey@partners.org
617 724-2764
Massachusetts General Hospital
24-Jun-1998


Page: 1 2 3

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. National Academies advisory: May 2 Symposium on International Science Policy
3. Awards & fellowships at the International & American Association for Dental Research General Session
4. Lectures, keynoters, symposia highlight International Dental Research meeting
5. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
6. International gathering of experts to share retinoblastoma breakthroughs
7. International trial of two microbicides begins
8. International gathering at UH examines top computer code
9. International trial finds benefits of breast MRI in women at high risk
10. International study provides culture-by-culture clues to family violence and abuse
11. St. Jude scientist wins International Society of Experimental Hematology award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... 20, 2017 (PRWEB) , ... ... ... a global provider of enterprise-grade IT operations analytics and application performance monitoring ... one of world’s largest healthcare services providers. , According to Peter Ohrenberger, ...
(Date:7/20/2017)... ... ... Doctors on Liens, the leading network of medical providers working on a ... Russell Horine, DC to their exclusive list of medical professionals. Horine Chiropractic is a ... the clinic director and his son Dr. Lee Horine and daughter-in-law Dr. Natalie Horine ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today ... existing adherence automation lines. The ATP® Mini and InspectRx® Mini are ... standard products, but at a size and price point that can help pharmacies ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... LINET, an ... latest innovation to their product line: the AVE 2 birthing bed. , Perfectly suitable ... bring a new level of comfort and efficiency to every phase of childbirth. The ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... million Health Resources and Services Administration (HRSA) grant to train predoctoral dental students ... care needs in rural and underserved areas. , The Predoctoral Pediatric Training Project ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  The global market for ... of approximately $394.1 million in 2016.  Although in early ... solid growth, in particular as a result of the ... and the recent introduction of a significant number of ... less-invasive testing of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
Breaking Medicine Technology:
Cached News: